ImageneBio (IMA) Stock Price
ImageneBio Price
Revenue at ImageneBio has contracted by 3.0% per year over the past 7 years to 800,000.00 USD. For ImageneBio, the net margin of -5,668.6% is down versus -110.1% a few years ago. The consensus 12-month price target for ImageneBio is 1.33 USD, about 68.3% below where the stock trades today. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus.
ImageneBio stock price
ImageneBio business model & stock analysis
Frequently asked questions about ImageneBio
Analysts currently set an average price target of 1.33 USD for the ImageneBio stock (median: 1.33 USD), implying -68.3 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the ImageneBio stock: 6 recommend buying, 1 holding and 1 selling. For 2026, analysts expect ImageneBio to generate revenue of 340,244.00 USD and earnings per share of -3.22 USD.
Converted at the current exchange rate, the ImageneBio share trades at 3.75 EUR (4.20 USD).
The ImageneBio share (IMA) is listed on 1 stock exchanges, including: NASDAQ (IKNA).
The expected revenue of ImageneBio is 340,244.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of ImageneBio is -36.00 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of ImageneBio is currently -1.30. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ImageneBio stock.
The price-to-sales ratio (P/S) of ImageneBio is currently 138.03. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ImageneBio stock.
The Eulerpool Quality Score for ImageneBio is 2/10.
The ISIN of ImageneBio is US45175G2075. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of ImageneBio is IMA. The ticker symbol is used to trade ImageneBio shares on the stock exchange.
ImageneBio stock
ImageneBio Peer Group
ImageneBio Ticker
All fundamentals and in-depth analysis of ImageneBio
Our stock analysis for ImageneBio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImageneBio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.